Brief: Laurus Labs Receives EIR From USFDA For API Facility
15/04/2025 07:33
April 15 (Reuters) - Laurus Labs Ltd LAUL.NS: RECEIVES EIR FROM USFDA FOR API FACILITY Source text: ID:nBSE4KYwfH Further company coverage: LAUL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig